100 Decisions. One Life.
For years, I have sat across boardroom tables, courtroom benches, founders' offices, and quiet conversations where people believed they were making routine choices.
Looking back, I realised something remarkable.
The decisions that changed their lives were rarely the loud, celebrated ones. They were the quiet choices that seemed ordinary in the moment, yet quietly redirected everything that followed.
That realisation became this book.
100 Decisions. One Life. is not a book about success in the conventional sense. It is about the moments that shape our character, judgment, relationships, reputation, and ultimately, our legacy.
Here is a short extract from the book that captures its essence:
"A different choice could have created a completely different life. The truth is both empowering and terrifying. None of us lives just one life. We live the life we create through the decisions we make.
Some decisions move us forward. Some delay our growth. Some save us from disaster. Some teach us lessons that success never could. But every decision leaves a footprint. Over time, those footprints form a path. And eventually that path becomes your life.
This book is not about success in the narrow sense of money or status. Success is an unreliable narrator. It often hides the real story. This book is about something deeper. It is about the decisions that quietly shape character, direction, relationships, reputation, and legacy."
If even one chapter prompts you to pause before making an important decision, challenges a long-held assumption, or encourages a more intentional way of living, then every hour spent writing this book will have been worthwhile.
After all, our lives are rarely transformed by a single dramatic event.
They are shaped, one decision at a time.
I hope 100 Decisions. One Life. becomes a thoughtful companion on that journey.
The book is available on Notion Press, Amazon, Flipkart, Kindle, etc.
Every founder begins by chasing opportunities. Every enduring founder is eventually defined by decisions. Hiring the right people. Letting go of control. Choosing investors. Building partnerships. Planning succession. Knowing when to exit. Never losing sight of purpose.
These decisions rarely make headlines, yet they determine whether a startup becomes a company or an institution.
My latest guest column explores the seven decisions that almost every founder will eventually face and why they deserve far more attention than valuations or funding announcements.
Which of these seven decisions do you believe is the hardest for founders to get right? Would love to hear your perspective.
https://t.co/kk2rBeZ3k3
AI Brain Fry Is Real.
AI is supposed to make us smarter. So why are thousands of professionals feeling mentally exhausted?
A major Harvard Business Review study of nearly 1,500 employees found that 14% are experiencing "AI Brain Fry", a new form of cognitive fatigue caused by excessive dependence on AI tools.
The biggest victims? Marketing professionals, software developers, HR, finance, and IT teams.
Is AI boosting your productivity... or quietly burning out your brain?
🎙️ The Mentor Talk with Hemant Batra
#AIBrainFry #ArtificialIntelligence #AI #HarvardBusinessReview #Burnout #FutureOfWork #Productivity #Workplace #Tech #SoftwareDevelopers #Marketing #HR #Finance #IT #Career #Leadership #MentalFatigue #WorkSmart #TheMentorTalk #HemantBatra
VIDEO | Type-2 Diabetes to benefit most from weekly insulin; Type-1 Diabetics still require meal-time insulin, says endocrinologist Dr. Ambrish Mithal.
Explaining the potential impact of once-weekly insulin, endocrinologist Dr. Ambrish Mithal (@DrAmbrishMithal) says, "Replacing one insulin injection a day with one injection a week means reducing the number of injections from 365 to 52 a year. That is a significant difference and a major step forward for people with Type 2 diabetes.
It can also be used in people with Type 1 diabetes, but they will still require short-acting insulin injections before each meal. Type 1 diabetes cannot be managed with basal insulin alone. As for gestational diabetes, it is not approved for use at the moment. There is nothing inherently negative about the therapy during pregnancy, but it has not yet been approved for that indication."
#WeeklyInsulin #Awiqli #Type2Diabetes #Type1Diabetes #BasalInsulin #GestationalDiabetes #DiabetesCare #Healthcare
(Full video available on PTI Videos - https://t.co/bIyFWTfmBd)
"A once-weekly injection will certainly improve patient acceptance of #insulin initiation and make it more likely that they will adhere to treatment. I believe this is a major step forward in diabetes management, particularly for people with Type 2 #diabetes who are starting basal insulin"
@PTI_News
What if the venture capital industry's biggest blind spot isn't technology... but women founders' talent? | India Specific - Global General
Imagine an asset class that consistently delivers stronger returns, better capital efficiency, lower burn rates and greater market expansion. Now imagine that it receives just 2.3% of global venture capital funding. That asset class isn't AI. It isn't climate tech. It isn't quantum computing. It's women founders.
At what point does this stop being a conversation about gender and become a conversation about poor capital allocation? If markets are supposed to reward performance, why does the data keep pointing in one direction while the money flows in another?
I've explored this uncomfortable paradox in the latest issue of Edward Zander Review. Perhaps the real question isn't whether women founders deserve more capital. It's whether investors can afford to keep overlooking one of the market's most underpriced opportunities.
Read the article. Then ask yourself: Is this an equality gap, or an investment failure?
For years, startup investors had to wait for an IPO or acquisition to exit. That's changing fast. India's booming secondary market is unlocking liquidity, with deal values and average transaction sizes hitting record highs. Here's why every founder, investor, and startup enthusiast should pay attention.
#Shorts #Startup #Startups #VentureCapital #PrivateEquity #SecondaryMarket #Investing #India #Finance #Business #IPO #Liquidity #Entrepreneur #Innovation #TheMentorTalk